Topical Drug Delivery System

Topical drug delivery systems (TDDS) have evolved significantly over the past several decades, offering targeted and localized therapy through the skin while minimizing systemic exposure. The skin, as the largest organ and a complex barrier, provides both accessibility and selectivity for drug administration. Conventional topical formulations, including ointments, creams, gels, and lotions, have proven effective for certain dermatological conditions; however, they often face limitations related to drug penetration, bioavailability, stability, and patient compliance. Advances in pharmaceutical technology have led to innovative delivery strategies such as nano-based carriers, liposomes, ethosomes, niosomes, transferosomes, solid lipid nanoparticles, and microneedle systems, which enhance therapeutic efficacy and overcome limitations of traditional formulations. TDDS also leverages physical and chemical enhancement methods, including sonophoresis, electroporation, iontophoresis, and chemical penetration enhancers, to improve drug permeation and retention. Future perspectives emphasize the integration of transdermal patches, hybrid chemical-physical approaches, and optimized formulation design to ensure stability, targeted delivery, and minimal side effects. The transition from conventional to carrier-mediated and advanced topical systems represents a promising avenue for effective treatment of localized and systemic conditions, including hydrophilic and macromolecular drugs, thereby improving patient adherence and overall therapeutic outcomes.